BiosensIC ApS: Financial statements 2024
CVR: 41757884
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BiosensIC ApS (CVR 41757884) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -2,388 and a net result of DKK -5,629 compared with DKK -18,396 the year before. Equity in the 2024 report amounted to DKK -41,251.
- Revenue
- DKK 0
- Gross Profit
- DKK -2,388
- Profit/Loss
- DKK -5,629
- Equity
- DKK -41,251
- Total Assets
- DKK 21,356
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -2 t. | -6 t. | -41 t. | - |
| 2023 | 0 | -2 t. | -18 t. | -36 t. | - |
| 2022 | - | -2 t. | -19 t. | -17 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BiosensIC ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -18,396.
About BiosensIC ApS
BiosensIC ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Allan Nogueras Nielsen and Leiying Zhu. The company is owned by Allan Nogueras Nielsen and Leiying Zhu. In 2025, the company reported a gross profit of DKK -12,099 and a net result of DKK -13,647 compared with DKK -5,629 the year before. Equity in the 2025 report amounted to DKK -54,898.